Colgate-Palmolive North America sales rise 4% in third quarter.
This article was originally published in The Rose Sheet
Executive SummaryCOLGATE-PALMOLIVE NORTH AMERICAN SALES UP 4% TO ABOUT $491 MIL. in the third quarter of 1996, the company reported Oct. 17. North American sales, which accounted for 22% of Colgate's net revenue for the period, were fueled by "strong growth in the U.S.," Colgate said. The U.S. operating group also "sharply improved" its gross profit margin and "significantly increased" its ad spend "both absolutely and as a percent of sales," the company added
You may also be interested in...
W3ll People is expected to add a relatively modest $7m to e.l.f. Beauty’s fiscal 2021 top line, but the brand has “major white space” opportunities, including at Target, e.l.f.’s longest-standing customer. Further, its plant-based product line includes 40 “EWG Verified” products, reflecting expertise e.l.f. is eager to tap.
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.